General Proximity Has Been Selected as One of the 24 ARPA-H Sprint for Women’s Health Awardees to Receive $3M to Develop Our Main Program
“Porem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.”
We are thrilled to announce that General Proximity has been selected as one of the 24 awardees of the highly competitive Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women’s Health.
Chosen from over 1,700 applicants representing 34 countries, this recognition underscores the transformative potential of our technology in addressing unmet needs in women’s health. This $3M award will support our team as we advance next-gen proximity therapeutics for high value undruggable targets in the women’s cancer space toward the clinic.
We are honored by ARPA-H's support on this groundbreaking program and remain committed to advancing solutions that redefine possibilities in women’s healthcare.
